| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $9,570,251 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01HD104418 | Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism | 000 | 1 | NIH | 4/22/2022 | $533,137 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01DE027343 | The role of platelets in protection against oral candidiasis | 000 | 4 | NIH | 12/17/2021 | $372,300 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01DE027343 | The role of platelets in protection against oral candidiasis | 001 | 4 | NIH | 4/21/2022 | $37,229 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | K22AI145849 | Functional Genetic Analysis of Klebsiella pneumoniae Hypervirulence | 000 | 2 | NIH | 6/10/2022 | $107,360 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AG057598 | Development of Attenuated Furoxans as Novel Therapies for Alzheimer's Disease | 000 | 5 | NIH | 2/2/2022 | $347,625 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AG057598 | Development of Attenuated Furoxans as Novel Therapies for Alzheimer's Disease | 001 | 5 | NIH | 6/7/2022 | $38,625 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01GM127656 | Effective targeting survivin dimerization interface with small molecule inhibitors | 000 | 4 | NIH | 5/12/2022 | $345,230 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AI144115 | Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast Cell Activation and Pulmonary Inflammation during Asthma | 000 | 5 | NIH | 1/31/2022 | $355,767 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 002 | 4 | NIH | 3/14/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 000 | 4 | NIH | 1/25/2022 | $318,077 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 001 | 4 | NIH | 2/1/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA230744 | Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | 004 | 4 | NIH | 4/28/2022 | $28,273 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AI146172 | Dissecting catalytic and regulatory functions of nonsegmented negative strandRNA viral polymerases | 000 | 4 | NIH | 5/24/2022 | $347,625 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA248304 | Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer | 000 | 3 | NIH | 2/7/2022 | $318,077 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA248304 | Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer | 001 | 3 | NIH | 5/3/2022 | $28,273 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01HL148585 | Mechanical Control of Coronary Angiogenesis in Myocardial Adaptation to Ischemia | 002 | 4 | NIH | 6/21/2022 | $476,065 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 000 | 3 | NIH | 3/30/2022 | $23,175 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01NS112642 | Cofilin Signaling in Hemorrhagic Stroke | 000 | 3 | NIH | 3/30/2022 | $363,075 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01HL152162 | Neural mechanisms of host-microbiota interaction in hypertension: a potential for bio-electronic medicine | 000 | 2 | NIH | 5/20/2022 | $439,862 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R00ES027869 | Behavioral and Neurological Effects of Developmental Pyrethroid Exposure in Rodents | 000 | 5 | NIH | 4/26/2022 | $249,000 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AI153496 | Understanding the proviral role for TRAF6 interaction with the viral protease in flavivirus replication and pathogenesis | 000 | 3 | NIH | 4/18/2022 | $386,250 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21AI164449 | A novel model to study COVID-19 and Hypertension | 000 | 2 | NIH | 5/18/2022 | $193,125 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | K22CA248616 | A transcription-independent role of HSF1 in tumorigenesis via suppression of AMPK | 000 | 2 | NIH | 6/21/2022 | $161,962 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AI155545 | Anti-inflammatory functions for non-transcriptional IRF3 | 000 | 2 | NIH | 1/20/2022 | $464,859 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01NS122534 | Pre- and postsynaptic pathways underlying the stress response in the adrenal medulla | 001 | 7 | NIH | 4/14/2022 | $365,961 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | H7600732 | Ryan White Part C Outpatient EIS Program | 00 | 21 | HRSA | 2/17/2022 | $129,312 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AG071332 | PPARG regulates osteocyte bioenergetics and function during aging | 001 | 2 | NIH | 6/3/2022 | $687,185 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21CA256462 | Targeting of eIF4A along with immunotherapy to overcome chemoresistance | 000 | 1 | NIH | 12/28/2021 | $216,686 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21MH126172 | Using pre-pandemic baseline data in people with and without PTSD to study effects of the COVID-19 pandemic on mental health and brain emotion circuits | 000 | 1 | NIH | 3/3/2022 | $224,288 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21MH126172 | Using pre-pandemic baseline data in people with and without PTSD to study effects of the COVID-19 pandemic on mental health and brain emotion circuits | 001 | 1 | NIH | 5/10/2022 | -$224,288 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21MH126172 | Using pre-pandemic baseline data in people with and without PTSD to study effects of the COVID-19 pandemic on mental health and brain emotion circuits | 001 | 1 | NIH | 5/10/2022 | $224,288 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21MH127500 | The effect of SHANK3 mutation in transgenic prairie voles on natural social behaviors and genetic mechanisms | 000 | 1 | NIH | 12/20/2021 | $255,500 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | F31CA260842 | Targeting Gut Microbiota Metabolites to Prevent Liver Cancer | 000 | 1 | NIH | 1/13/2022 | $40,138 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | F31CA260842 | Targeting Gut Microbiota Metabolites to Prevent Liver Cancer | 001 | 1 | NIH | 1/13/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R21MH125277 | A large sample machine learning network analysis of vertex cortical thickness measures for high resolution definition of PTSD related cortical structure abnormalities | 000 | 1 | NIH | 1/17/2022 | $225,065 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | T32GM144873 | Training in Molecular and translational Cell Dynamics | 000 | 1 | NIH | 4/28/2022 | $214,277 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | T32GM144873 | Training in Molecular and translational Cell Dynamics | 001 | 1 | NIH | 6/2/2022 | -$4 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01AI165521 | Novel antiviral mechanisms of the interferon system | 000 | 1 | NIH | 5/25/2022 | $450,507 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01CA211904 | Molecular targeting the translational control axis in Wnt/beta-catenin signaling pathway? | 000 | 6 | NIH | 5/25/2022 | $344,884 |
| | 2022 | 2022 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 00 | 17 | CDC | 6/6/2022 | $86,963 |
| | 2022 | 2021 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | F31HL160178 | Inhalation Exposure to Aerosolized Cyanotoxins Worsens Pre-Existing Asthma via Activation of Granulocytic Inflammation | 000 | 1 | NIH | 3/1/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | T03OH008605 | NIOSH Training Project Grant (TPG): Industrial Hygiene - University of Toledo | 00 | 17 | CDC | 6/6/2022 | $0 |
| | 2022 | 2021 | University Of Toledo, The | 3000 Arlington Ave | Toledo | OH | 43614-2595 | LUCAS | USA | U7723072 | Area Health Education Centers Point of Service Maintenance and Enhancement | 01 | 11 | HRSA | 10/18/2021 | $0 |
| | 2022 | 2021 | University Of Toledo, The | 3000 Arlington Ave | Toledo | OH | 43614-2595 | LUCAS | USA | U7723072 | Area Health Education Centers Point of Service Maintenance and Enhancement | 03 | 11 | HRSA | 3/18/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | U7723072 | Area Health Education Centers Point of Service Maintenance and Enhancement | 04 | 11 | HRSA | 5/5/2022 | $0 |
| | 2022 | 2021 | University Of Toledo, The | 3000 Arlington Ave | Toledo | OH | 43614-2595 | LUCAS | USA | U7723072 | Area Health Education Centers Point of Service Maintenance and Enhancement | 02 | 11 | HRSA | 2/1/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R00GM118885 | Intrarenal Arteries Sense N-formyl Peptides Leading to Vascular Injury in Sepsis | 000 | 5 | NIH | 4/15/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01HL148585 | Mechanical Control of Coronary Angiogenesis in Myocardial Adaptation to Ischemia | 001 | 3 | NIH | 11/25/2021 | $395,482 |
| | 2022 | 2021 | UNIVERSITY OF TOLEDO, THE | 3000 ARLINGTON AVE | TOLEDO | OH | 43614-2595 | LUCAS | USA | R01HL149762 | Formyl peptide receptor activation induces vascular plasticity and remodeling inhypertension | 001 | 1 | NIH | 3/8/2022 | $0 |
|
